Literature DB >> 16930560

Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity.

Sarah L Doyle1, Luke A J O'Neill.   

Abstract

Toll-like receptors (TLRs) are key components of the innate immune system, functioning as pattern recognition receptors that recognise a wide range of microbial pathogens. TLRs represent a primary line of defence against invading pathogens in mammals, plants and insects. Recognition of microbial components by TLRs triggers a cascade of cellular signals that culminates in the activation of NFkappaB which leads to inflammatory gene expression and clearance of the infectious agent. The history of NFkappaB began with the TLR4 ligand lipopolysaccharide (LPS), a component of the cell wall of Gram-negative bacteria, since this was the stimulus first used to activate NFkappaB in pre-B-cells. However, since those early days it has been a circuitous route, made possible by drawing on information provided by many different fields, that has led us not only to the discovery of TLRs but also to an understanding of the complex pathways that lead from TLR ligation to NFkappaB activation. In this review we will summarize the current knowledge of TLR-mediated NFkappaB activation, and also the recent discoveries that subtle differences in kappaB binding sequences and NFkappaB dimer formation result in specific gene expression profiles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930560     DOI: 10.1016/j.bcp.2006.07.010

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  214 in total

Review 1.  Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses.

Authors:  Egest J Pone; Hong Zan; Jingsong Zhang; Ahmed Al-Qahtani; Zhenming Xu; Paolo Casali
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

Review 2.  Neonatal programming of innate immune function.

Authors:  S J Spencer; M A Galic; Q J Pittman
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-02       Impact factor: 4.310

3.  IgE-dependent sensitization increases responsiveness to LPS but does not modify development of endotoxin tolerance in mast cells.

Authors:  Jaciel Medina-Tamayo; Alfredo Ibarra-Sánchez; Alejandro Padilla-Trejo; Claudia González-Espinosa
Journal:  Inflamm Res       Date:  2010-07-13       Impact factor: 4.575

4.  Metalloprotease type III effectors that specifically cleave JNK and NF-κB.

Authors:  Kobi Baruch; Lihi Gur-Arie; Chen Nadler; Simi Koby; Gal Yerushalmi; Yinon Ben-Neriah; Orli Yogev; Eitan Shaulian; Chen Guttman; Raz Zarivach; Ilan Rosenshine
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

5.  Asiatic Acid Inhibits Lipopolysaccharide-Induced Acute Lung Injury in Mice.

Authors:  Zhiling Li; Xianzhong Xiao; Mingshi Yang
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

Review 6.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

7.  Chronic stress promotes lymphocyte reduction through TLR2 mediated PI3K signaling in a β-arrestin 2 dependent manner.

Authors:  Hui Li; Lin Chen; Ying Zhang; Gene Lesage; Yi Zhang; Yan Wu; Gregory Hanley; Shenggang Sun; Deling Yin
Journal:  J Neuroimmunol       Date:  2010-12-22       Impact factor: 3.478

8.  The Role of Toll-Like Receptors in Diabetes-Induced Inflammation: Implications for Vascular Complications.

Authors:  Ishwarlal Jialal; Harmeet Kaur
Journal:  Curr Diab Rep       Date:  2012-02-08       Impact factor: 4.810

Review 9.  Long noncoding RNAs in innate and adaptive immunity.

Authors:  Katherine A Fitzgerald; Daniel R Caffrey
Journal:  Curr Opin Immunol       Date:  2013-12-22       Impact factor: 7.486

10.  Chronic restraint stress promotes immune suppression through toll-like receptor 4-mediated phosphoinositide 3-kinase signaling.

Authors:  Yi Zhang; Ying Zhang; Junying Miao; Gregory Hanley; Charles Stuart; Xiuli Sun; Tingting Chen; Deling Yin
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.